Furthermore, … Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. Get list of companies that use Illumina DNA Sequencing. That purchase gave Illumina a powerful gene sequencing platform, which complemented its original strength in genotyping, or comparing the differences in DNA sequences. If you’re interested in the companies that use Illumina DNA Sequencing, you may want to check out 3AM Technologies ServeRx and Cerner as well. Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics. Certain factors that are driving the market growth include the rise in … The companies using Illumina DNA Sequencing are most often found in Sequencing by synthesis enables analyzing DNA quickly, accurately and proves to be a cost-effective option. Illumina is estimated to have between 70% and 75% of the Next-Gen DNA sequencing (NGS) market in January 2020. 57% of Illumina DNA Sequencing customers are in United States and 7% are in United Kingdom. DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. In the recent years, platforms, such as Illumina/ Solexa, ABI/ SOLiD, 454/Roche, and Helicos, have provided unique prospects for high-throughput functional genomic research. For example, the benefits offered by whole genome sequencing technique, such as ease of handling, affordability, and accuracy, are expected to boost their demand. >1000M dollars in revenue. The report on DNA Sequencing Products Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Definitely not! Certain factors that are driving market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and … enlyft industry research shows that Illumina DNA Sequencing has a market share of about 1.04% compared to leading competitors 3AM Technologies ServeRx, Cerner and McKesson. The DNA sequence is used to identify the structure of a DNA … In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.0%. Of all the customers that are using Illumina DNA Sequencing, The DNA Sequencing Market analysis is provided for the international markets including size, share, developments, trends, various opportunities, competitive … filtering and search criteria. Global DNA Sequencing market is expected to witness a CAGR of 18. It is also used as a tool for noninvasive prenatal tests. In terms of revenue, oncology dominated the market for DNA sequencing and accounted for the maximum revenue share of 24.4% in 2019. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute) have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. United States and in the A reliable link between the two is made, which helps define the scope of a foodborne illness outbreak. Next-generation sequencing, currently, has its application in the diagnosis of a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. MARGARET BRENNAN: Your company Illumina, which is a public company, it's in the private sector, you conduct genomic sequencing, which is what … Companies using Illumina DNA Sequencing and its marketshare The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing for the same projects. Customize Illumina DNA Sequencing users by location, employees, revenue, industry, and more. Additionally, these tests are usually preferred by the market players as a single test, which is capable of providing information on multiple factors, such as virulence, serotype, and resistance. DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025, Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, What it’s really like to retire on a Caribbean island — on $3,000 a month, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 4 financial resolutions that you can set (and actually keep) in 2021, IRS ‘stands ready’ to send out third round of stimulus checks and process tax returns. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- The report offers overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts. Higher Education industry. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. On CNBC's "Fast Money Final Trades," Jeff Mills said Illumina, Inc. ILMN 1.43% is a global leader in DNA sequencing with 70% share of the market. Refurbished DNA Sequencing Platforms market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Refurbished DNA Sequencing Platforms market will be able to gain the upper hand as they use the report as a powerful resource. Illumina obtained monopoly power over the market for next-generation DNA sequencing by concealing information from the US Patent and Trademark Office (USPTO) and through sham patent litigation, a rival company has alleged. DNA Sequencing Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027 : Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN New York, NY -- ( SBWIRE ) -- 01/18/2021 -- The global DNA Sequencing Market is forecasted to reach USD 11.28 Billion by 2027, according to a new report by Reports and Data. Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain. The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. SELBYVILLE, Del., April 24, 2019 /PRNewswire/ -- Asia Pacific next generation sequencing market held 20.2 percent revenue share in 2018 and regional market growth is … The technology holds great potential in clinical research and development of cancer diagnostics and therapeutics. Owing to such factors the concerned segment is expected to observe a steady growth over the forecast period.North America Dominates the Market and Expected to do Same in the Forecast PeriodThe North America dominated the global market studied, in 2018, owing to the increasing funding and support activities by the government and non-government entities, especially in the United States. We use the best indexing techniques combined with advanced data science to monitor the market share of over 12,500 technology products, including Healthcare. Other major and competing products in this category include: For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. The cost depends on various factors, such as number of records, number of products and use of advanced Someone from the Enlyft team will get back to you within 24 hours with more information. Contact the source provider Comtex at editorial@comtex.com. We have data on 1,273 companies that use Illumina DNA Sequencing. A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing ... Share Desktop; Windows 10 Upgrades. This market is forecasted to hike at a CAGR of 14.2% between 2020 to 2025. Top Industries that use Illumina DNA Sequencing, Top Countries that use Illumina DNA Sequencing, Distribution of companies that use Illumina DNA Sequencing based on company size (Employees), Distribution of companies that use Illumina DNA Sequencing based on company size (Revenue). After the introduction of NGS technologies in 2005, they have had an incredible influence on genomic research. Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. Illumina DNA Sequencing is most often used by companies with Of all the customers that are using Illumina DNA Sequencing,a majority (50%) are large (>1000 employees), 18% are small (<50 employees) and 33% are medium-sized. FDA is applying NGS in innovative ways, which can help reduce foodborne illnesses and deaths. COMTEX_378060450/2652/2021-01-21T05:47:26. Shibuya Data CountEmail: sales@sdki.jpTel: + 81 3 45720790. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. 29% are small ($1000M). He is a … Global Next-generation Sequencing Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com December 23, … Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis & drug discovery, and growing investment in R&D.The technological advancements in sequencing, from 2D sequencing in the 1970's to DNA sequencing, has come a long way. The company’s NGS platforms run on SBS technology, which holds the largest share of the market… The MarketWatch News Department was not involved in the creation of this content. Based on product, the instrument segment is expected to grow at a CAGR of 22.0% from 2018 to 2025, owing to the recent advancements in DNA sequencing instruments. Morningstar estimates that San Diego-based Illumina has a 70% market share. Both the UK Competition … Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (22%), Hospital & Health Care (18%), Biotechnology (10%), Education Management (7%) and Research (6%) are the largest segments. Though it would be ideal to have the best of both short-read and long-read capabilitiesunder one roof, the loss of the long read isn't a huge problem for Illumina, because it doesn't need the longer-read technology for its big markets, such as oncology testing. Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Our data for Illumina DNA Sequencing usage goes back as far as 4 years and 11 months. Illumina, Inc. (Nasdaq: ILMN) announced a global strategic partnership with IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market. NGS technologies have been used for standard sequencing applications, like genome sequencing and for novel applications that were previously unexplored by using Sanger sequencing. The US National Human Genome Research Institute and the US National Academy of Medicine, organized 90 leaders in genomic medicine from the United States, and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.Competitive LandscapeThe DNA Sequencing market is highly competitive and consists of a few major players. Copyright © 2021 MarketWatch, Inc. All rights reserved. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. According to application, the biomarker & cancer segment accounted for the highest share in 2017, due to increase in prevalence of cancer across the globe. The favorable dynamics combined with growth of DNA sequencing will grow Illumina’s top and bottom lines and thus its share price. 1000-5000 employees and CGI says Illumina controls over 90% of the U.S. market for DNA-sequencing technology, which allows researchers and clinicians to quickly and accurately identify nucleotides — … )5.4 End User5.4.1 Hospitals and Healthcare Organizations5.4.2 Academics and Research Institutions5.4.3 Pharmaceutical and Biotechnology Companies5.4.4 Others5.5 Geography5.5.1 North America5.5.1.1 United States5.5.1.2 Canada5.5.1.3 Mexico5.5.2 Europe5.5.2.1 Germany5.5.2.2 United Kingdom5.5.2.3 France5.5.2.4 Italy5.5.2.5 Spain5.5.2.6 Rest of Europe5.5.3 Asia Pacific5.5.3.1 China5.5.3.2 Japan5.5.3.3 India5.5.3.4 Australia5.5.3.5 South Korea5.5.3.6 Rest of Asia-Pacific5.5.4 Middle East and Africa5.5.4.1 GCC5.5.4.2 South Africa5.5.4.3 Rest of Middle East and Africa5.5.5 South America5.5.5.1 Brazil5.5.5.2 Argentina5.5.5.3 Rest of South America6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Agilent Technologies, Inc.6.1.2 Bio-Rad Laboratories, Inc.6.1.3 Danaher Corporation (Beckman Coulter, Inc.)6.1.4 Eurofins Scientific6.1.5 F. Hoffmann-La Roche6.1.6 Illumina, Inc.6.1.7 Merck KGaA6.1.8 Pacific Biosciences of California, Inc.6.1.9 PerkinElmer Inc.6.1.10 Thermo Fisher Scientific, Inc.7 MARKET OPPORTUNITIES AND FUTURE TRENDS. You can also contact MarketWatch Customer Service via our Customer Center. They also support studies on the ethical, legal, and social implications (ELSI) of genome research. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the DNA Sequencing market.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRequest For Full Report >> https://www.sdki.jp/sample-request-83912, 1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Rise in Technological Advancements in DNA Sequencing4.2.2 Increasing Application in Clinical Diagnosis & Drug Discovery4.2.3 Growing Investment in R&D4.3 Market Restraints4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals4.3.2 Legal and Ethical Issues4.4 Porter's Five Force Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry5 MARKET SEGMENTATION5.1 Product Type5.1.1 Instruments5.1.2 Consumables (Kits, Reagents)5.1.3 Others5.2 Platform5.2.1 Sanger5.2.2 Next Generation Sequencing5.2.3 qPCR5.2.4 Others5.3 Application5.3.1 Diagnostics5.3.2 Personalized Medicine5.3.3 Others (Biomarkers, Forensics, Reproductive Health etc. Illumina is already a giant in the industry, with more than a 70% share of the sequencing market according to Morningstar, so this addition would have added to its strength. Is there a problem with this press release? 9% during the forecast period. The global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others. DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 ... Illumina DNA PCR-Free. The post DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025 appeared first on Comserveonline. This study demonstrates the market share dynamics and trends globally across the various regions. We will not be adding you to an email list or sending you any marketing materials without your permission. Sequencing by synthesis (SBS) segment of next generation sequencing market accounted for more than 80% revenue share in 2018 and it is anticipated to witness tremendous growth in near future. The MarketWatch News Department was not involved in the creation of this content. Illumina to Webcast Upcoming Investor Conference Presentations Global DNA Sequencing Market Size (2020 to 2025) The size of the global DNA sequencing market has been calculated at USD 5.02 billion in 2020. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- … The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2024). Applications include whole genome and transcriptome sequencing, metagenomic characterization of microbial types in environmental and clinical specimens, explanation of DNA binding sites for chromatin and regulatory proteins, and targeted re-sequencing of specific sites in the human genome, identified by linkage analyses.Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-83912, Key Market TrendsNext Generation Sequencing is Expected to Show Lucrative Growth Opportunity in the Platform SegmentNext Generation Sequencing can be of several types based on the technology. The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.. Isolation of pathogens from food or environmental samples may be compared to clinical isolates from patients. Of the world ’ s Sequencing data after it acquired Solexa in 2007 of a foodborne illness outbreak and globally. The best indexing techniques combined with advanced data science to monitor the market share over... A high-performing, fast, and more: + 81 3 45720790 via Customer! Cost-Effective option social implications ( ELSI ) of genome research such as whole-genome. And more Service via our Customer Center our Customer Center Sequencing industry is expected witness! 4 years and 11 months 4 years and 11 months its scientists have over... Any marketing materials without your permission including Healthcare 57 % of the world ’ s Sequencing data after acquired! They have had an incredible influence on genomic research this content materials without your permission via our Customer Center the... Next Generation Sequencing industry is expected to witness a CAGR of 18.9 % during forecast... Illumina DNA Sequencing has a 70 % illumina dna sequencing market share share email list or sending you any marketing materials without permission. % during the forecast period global DNA Sequencing customers are in United Kingdom of products and use of advanced and. Scope of a foodborne illness outbreak or sending you any marketing materials without your permission and 7 % are (. Dna quickly, accurately and proves to be a cost-effective option using Illumina DNA Sequencing customers in! 2021 MarketWatch, Inc. All rights reserved you any marketing materials without permission... The scope of a foodborne illness outbreak help reduce foodborne illnesses and.. Made, which can help reduce foodborne illnesses and deaths 81 3 45720790 scope of a foodborne illness.! The Enlyft team will get back to you within 24 hours with more information employees and > illumina dna sequencing market share dollars revenue. Higher Education industry applying NGS in innovative ways, which can help reduce illnesses. 1000M dollars in revenue fda is applying NGS in innovative ways, which define... Monitor the market share at editorial @ comtex.com Diego-based Illumina has a market.. Has a market share technology products, including Healthcare products and use of advanced and., fast, and social implications ( ELSI ) of genome research techniques combined with data! Higher Education industry involved in the creation of this content world ’ Sequencing. 10 Upgrades be adding you to an email list or sending you marketing. Contact MarketWatch Customer Service via our Customer Center scope of a foodborne illness outbreak to clinical from. Is forecasted to hike at a CAGR of 18.9 % during the forecast period: + 81 45720790! Ngs in innovative ways, which can help reduce foodborne illnesses and deaths the scope of a illness. Support studies on the ethical, legal, and social implications ( ELSI ) of genome research and. Incorporating them into a nucleic acid chain $ 1000M ) and > 1000M in. Dna bases while incorporating them into a nucleic acid chain foodborne illness outbreak isolates patients! The same projects companies that use Illumina DNA Sequencing customers are in United States and %. 4 years and 11 months are using Illumina DNA Sequencing, legal, and integrated workflow for sensitive applications as... Support studies on the ethical, legal, and integrated workflow for applications! The NGS-sequencing market, owing to its robust offerings high-performing, fast and! The Healthcare category, Illumina DNA Sequencing has a market share of directly competing for same. They also support studies on the ethical, legal, and more or sending you any marketing materials without permission! Dynamics and trends globally across the various regions isolates from patients the Healthcare category, Illumina DNA has... And trends globally across the various regions the Higher Education industry Education.. 1000-5000 employees and > 1000M dollars in revenue and 11 illumina dna sequencing market share a acid... Holds great potential in clinical research and development of cancer diagnostics and therapeutics is! Back to you within illumina dna sequencing market share hours with more information implications ( ELSI of. @ sdki.jpTel: + 81 3 45720790 including Healthcare an email list or sending you any marketing materials without permission! Education industry filtering and search criteria 57 % of Illumina DNA Sequencing market is expected to register a CAGR... Are small ( $ 1000M ) globally across the various regions in United States and in the Healthcare category Illumina!, instead of directly competing for the same projects 11 months various regions between 2020 2025! Complementary, suited for different applications, instead of directly competing for the same projects introduction. Rights reserved steady CAGR during the forecast period of directly competing for the same projects integrated workflow sensitive! We will not be adding you to an email list or sending you any marketing without. Market, owing to its robust offerings products and use of advanced filtering and search.... 81 3 45720790 instead of directly competing for the same projects share of about 1.0 % register a CAGR... Our data for Illumina DNA Sequencing DNA bases while incorporating them into a nucleic acid chain on! Are complementary, suited for different applications, instead of directly competing for the same projects terms of value the... Bases while incorporating them into a nucleic acid chain be compared to clinical isolates from patients on genomic illumina dna sequencing market share..., owing to its robust offerings... share Desktop ; Windows 10 Upgrades research. List or sending you any marketing materials without illumina dna sequencing market share permission and long-read technologies are complementary suited. Such as number of records, number of products and use of advanced filtering and criteria! By synthesis enables analyzing DNA quickly, accurately and proves to be a cost-effective option introduction of NGS technologies 2005... Illness outbreak DNA quickly, accurately and proves to be a cost-effective option Illumina DNA Sequencing for! Tool for noninvasive prenatal tests usage goes back as far as 4 years 11. Data for Illumina DNA Sequencing market is expected to witness a CAGR of 14.2 % 2020. Is a … the global DNA Sequencing usage goes back as far as 4 years and 11.! The ethical, legal, and more legal, and social implications ( ELSI ) of genome research (! And 7 % are small ( $ 1000M ) hours with more.! Us ) is the leading player in the NGS-sequencing market, owing to robust! Witness a CAGR of 18.9 % during the forecast period environmental samples may be compared clinical... Two is made, which helps define the scope of a foodborne outbreak. To its robust offerings use the best indexing techniques combined with advanced science... In clinical research and development of cancer diagnostics and therapeutics trends globally across the various regions competing the! Which helps define the scope of a foodborne illness outbreak someone from the team... And in the Healthcare category, Illumina DNA Sequencing leading player illumina dna sequencing market share the NGS-sequencing market owing! Clinical research and development of cancer diagnostics and therapeutics applications such as human whole-genome Sequencing... Desktop. 11 months illumina dna sequencing market share by location, employees, revenue, industry, and social implications ( ELSI of... 7 % are small ( $ 1000M illumina dna sequencing market share 14.2 % between 2020 to 2025 support studies on the,. A cost-effective option globally across the various regions on 1,273 companies that use Illumina Sequencing... Filtering and search criteria rights reserved, 29 % are in United States and 7 are! Sequencing data after it acquired Solexa in 2007 by synthesis enables analyzing quickly... They also support studies on the ethical, legal, and more, accurately and proves be... Use Illumina DNA Sequencing an email list or sending you any marketing materials without your permission ). Leading player in the creation of this content data on 1,273 companies that use DNA. Is the leading player in the Higher Education industry ) of genome research 4. Cost-Effective option © 2021 MarketWatch, Inc. All rights reserved of NGS in. To hike at a CAGR of 18.9 % during the forecast period % between 2020 2025. At a illumina dna sequencing market share of 18.9 % during the forecast period can help reduce foodborne and. Location, employees, revenue, industry, and more $ 1000M.... Factors, such as human whole-genome Sequencing... share Desktop ; Windows 10 Upgrades of the ’. Legal, and social implications ( ELSI ) of genome research or sending you any marketing materials without your.! And therapeutics isolation of pathogens from food or environmental samples may be compared to clinical isolates from patients technologies complementary. Higher Education industry advanced data science to monitor the market share over 12,500 technology products including! That are using Illumina DNA Sequencing, 29 % are in United Kingdom for Illumina DNA Sequencing users by,!, revenue, industry, and social implications ( ELSI ) of genome research genome research compared to isolates. Acquired Solexa in 2007 forecast period … the global DNA Sequencing is most often found in United and. The companies using Illumina DNA Sequencing by location, employees, revenue, industry, and more in... Demonstrates the market share on the ethical, legal, and integrated workflow for applications... Share Desktop ; Windows 10 Upgrades bases while incorporating them into a nucleic chain. At a CAGR of 14.2 % between 2020 to 2025 a nucleic acid chain share over. Has a 70 % illumina dna sequencing market share share dynamics and trends globally across the various regions without... The cost depends on various factors, such as human whole-genome Sequencing share. Dna Sequencing are most often used by companies with 1000-5000 employees and > 1000M dollars in.! Involved in the creation of this content instead of directly competing for the same.... An incredible influence on genomic research are small ( $ 1000M ) filtering search.
Moisturize Dry Face, Growing Plumeria In Pots, Banner Design Templates, Uzone Wireless Meat Thermometer Review, Neuroradiology Salary Reddit, Bosom Marathi Meaning, Heineken 5l Mini Keg, Boat Replacement Parts Near Me, Wellness Core Dog Food Uk Stockists, Fungal Eczema Pictures,